tm
Seeing Is Believing
tm
Seeing Is Believing
Pharmaceutical Retailers - Industry
MEDS is currently covered by 2 analysts with an average price target of $15.11. This is a potential upside of $8.45 (126.88%) from yesterday's end of day stock price of $6.66.
Trxade Group's activity chart (see below) currently has 2 price targets and 4 ratings on display. The stock rating distribution of MEDS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 174.5 days.
Highest price target for MEDS is $1.25, Lowest price target is $1.25, average price target is $15.11.
Most recent stock forecast was given by CONSTANTINE DAVIDES from JMP on 16-May-2023. First documented stock forecast 26-Feb-2021.
Currently out of the existing stock ratings of MEDS, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
1.25
$-7.81 (-86.20%)
67.5
11 months 6 days ago
0/2 (0%)
$-3.7 (-74.75%)
Buy
26
$16.94 (186.98%)
225
1 years 25 days ago
1/2 (50%)
$20.6 (381.48%)
349
What is MEDS (Trxade Group) average time for price targets to be met?
Which analyst has the current highest performing score on MEDS (Trxade Group) with a proven track record?
Which analyst has the current lower performing score on MEDS (Trxade Group) with a proven track record?
Which analyst has the most public recommendations on MEDS (Trxade Group)?
Which analyst is the currently most bullish on MEDS (Trxade Group)?
Which analyst is the currently most reserved on MEDS (Trxade Group)?
